12 research outputs found
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
The majority of patients with Wegener's granulomatosis (WG) are chronic nasal carriers of Staphylococcus aureus. Chronic nasal carriage of S. aureus is associated with an increased risk of developing a relapse of the disease. The mechanism by which this occurs is still unknown. We hypothesized that a cationic protein of S. aureus, staphylococcal acid phosphatase (SAcP), acts as a planted antigen and initiates glomerulonephritis and vasculitis in patients with WG. In order to test the hypothesis that SAcP can act as a planted antigen in WG, we studied the ability of SAcP to bind to human umbilical vein endothelial cells (HUVEC) and human glomerular endothelial cells. We also studied whether this binding can be prevented by preincubation with an anionic protein, and whether binding of SAcP activates endothelial cells. We also evaluated whether antibodies in sera of patients with WG are able to bind to endothelial cell-bound SAcP. The results show that SAcP can act as a planted antigen by binding to both types of endothelial cells in a concentration-dependent manner. Binding of concentrations as low as 4 mu g/ml can be detected on HUVEC within 5 min of incubation. Binding of SAcP to endothelial cells was charge-dependent but did not activate endothelial cells. Finally, endothelial cell-bound SAcP was recognized by sera of patients with WG. The data suggest a possible pathogenic role for SAcP by acting as a planted antigen thereby initiating glomerulonephritis and vasculitis in patients with WG
A new microfluidic model that allows monitoring of complex vascular structures and cell interactions in a 3D biological matrix
Microfluidic organ-on-a-chip designs are used to mimic human tissues, including the vasculature. Here we
present a novel microfluidic device that allows the interaction of endothelial cells (ECs) with pericytes and
the extracellular matrix (ECM) in full bio-matrix encased 3D vessel structures (neovessels) that can be
subjected to continuous, unidirectional flow and perfusion with circulating immune cells. We designed a
polydimethylsiloxane (PDMS) device with a reservoir for a 3D fibrinogen gel with pericytes. Open channels
were created for ECs to form a monolayer. Controlled, continuous, and unidirectional flow was introduced
via a pump system while the design facilitated 3D confocal imaging. In this vessel-on-a-chip system, ECs
interact with pericytes to create a human cell derived blood vessel which maintains a perfusable lumen for
up to 7 days. Dextran diffusion verified endothelial barrier function while demonstrating the beneficial role
of supporting pericytes. Increased permeability after thrombin stimulation showed the capacity of the
neovessels to show natural vascular response. Perfusion of neovessels with circulating THP-1 cells
demonstrated this system as a valuable platform for assessing interaction between the endothelium and
immune cells in response to TNFα. In conclusion: we created
Reader response: Comparative safety and efficacy of combined IVT and MT with direct MT in large vessel occlusion
status: publishe